Non-Opioid Pain Relief Device Market

Non-Opioid Pain Relief medicine and other tools can help people reduce or even avoid the use of narcotics.
Pain management professionals use a variety of tools to ease discomfort, including other prescription and over-the-counter medications, as well as psychological interventions and mind-body therapies to minimize opioid use. Melissa Durham, PharmD, MACM, associate professor of clinical pharmacy at the USC School of Pharmacy, and Faye Weinstein, PhD, clinical associate professor of anesthesiology and psychiatry & the behavioral sciences, and director of pain management psychology at the Keck School of Medicine of USC, weigh in on the latest therapies available for non-opioid treatment.
Non-Opioid Pain Relief Device Market contains market size and forecasts of Non-Opioid Pain Relief Device in global, including the following market information:
Global Non-Opioid Pain Relief Device Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Non-Opioid Pain Relief Device Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Non-Opioid Pain Relief Device companies in 2021 (%)
The global Non-Opioid Pain Relief Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Implantable Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Non-Opioid Pain Relief Device include Abbott Laboratories, Bayer AG, Bioelectronics Corporation, Boston Scientific Corporation, Medtronic plc, Koninklijke Philips N.V., NeuroMetrix Inc., Nuvectra Corporation and Omron Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Non-Opioid Pain Relief Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Opioid Pain Relief Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Opioid Pain Relief Device Market Segment Percentages, by Type, 2021 (%)
Implantable Device
Non-Implantable Device
Radiofrequency Ablation
Other Emerging Technologies
Global Non-Opioid Pain Relief Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Opioid Pain Relief Device Market Segment Percentages, by Application, 2021 (%)
Hospitals
Pain Management Centers
Homecare
Global Non-Opioid Pain Relief Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Non-Opioid Pain Relief Device Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Opioid Pain Relief Device revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Non-Opioid Pain Relief Device revenues share in global market, 2021 (%)
Key companies Non-Opioid Pain Relief Device sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Non-Opioid Pain Relief Device sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Bayer AG
Bioelectronics Corporation
Boston Scientific Corporation
Medtronic plc
Koninklijke Philips N.V.
NeuroMetrix Inc.
Nuvectra Corporation
Omron Corporation
Stryker Corporation
SPR Therapeutics, LLC
Stimwave LLC
Thermotek Inc.
Zynex Medical